Arbutus Biopharma Corp - Common Shares, without par value (ABUS)

CUSIP: 03879J100

Q1 2022 13F Holders as of 31 Mar 2022

Type / Class
Equity / Common Shares, without par value
Shares outstanding
193,679,354
Total 13F shares
43,886,769
Share change
+2,666,351
Total reported value
$130,608,351
Put/Call ratio
135%
Price per share
$2.98
Number of holders
111
Value change
+$4,239,945
Number of buys
52
Number of sells
51

Quarterly Holders Quick Answers

What is CUSIP 03879J100?
CUSIP 03879J100 identifies ABUS - Arbutus Biopharma Corp - Common Shares, without par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Arbutus Biopharma Corp - Common Shares, without par value (ABUS) as of Q1 2022

As of 31 Mar 2022, Arbutus Biopharma Corp - Common Shares, without par value (ABUS) was held by 111 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 43,886,769 shares. The largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, Hudson Bay Capital Management LP, BROOKFIELD ASSET MANAGEMENT INC., Two Seas Capital LP, Assenagon Asset Management S.A., MILLENNIUM MANAGEMENT LLC, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, and Nuveen Asset Management, LLC. This page lists 111 institutional shareholders reporting positions in this security for the Q1 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.